Articles published by Jupiter Endovascular, Inc.

Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial at EuroPCR 2026

May 20, 2026

From Jupiter Endovascular, Inc.

Via Business Wire

Jupiter Endovascular Announces Completion of Enrollment in SPIRARE II Pivotal Trial

February 04, 2026

From Jupiter Endovascular, Inc.

Via Business Wire

Jupiter Endovascular Closes Oversubscribed Series B Financing, Surpassing $40 Million Target

October 07, 2025

From Jupiter Endovascular, Inc.

Via Business Wire

Jupiter Endovascular Appoints Fred Ong as Chief Financial Officer

February 26, 2025

From Jupiter Endovascular, Inc.

Via Business Wire

Jupiter Endovascular Announces First U.S. Patient Treated With Vertex Pulmonary Embolectomy System Using Endoportal Control

October 25, 2024

From Jupiter Endovascular, Inc.

Via Business Wire

Jupiter Endovascular Announces First Patients Successfully Treated in First Clinical Study of Vertex Pulmonary Embolectomy System Using Endoportal Control

September 19, 2024

From Jupiter Endovascular, Inc.

Via Business Wire

Jupiter Endovascular Receives FDA Approval for U.S. Pivotal Study of Vertex Pulmonary Embolectomy System Using Endoportal Control

August 29, 2024

From Jupiter Endovascular, Inc.

Via Business Wire

Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism

August 15, 2024

From Jupiter Endovascular, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.